Daiichi Sankyo File Changes In Domestic Application For Inavir For Flu Prevention
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo has filed an application for partial changes to its antiviral Inavir (laninamivir) in relation to influenza prevention.